168 related articles for article (PubMed ID: 22334713)
1. Estradiol release kinetics determine tissue response in ovariectomized rats.
Otto C; Kantner I; Nubbemeyer R; Schkoldow J; Fuchs I; Krahl E; Vonk R; Schüler C; Fritzemeier KH; Erben RG
Endocrinology; 2012 Apr; 153(4):1725-33. PubMed ID: 22334713
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic genistein treatment in mammary gland, uterus, and vagina.
Rimoldi G; Christoffel J; Seidlova-Wuttke D; Jarry H; Wuttke W
Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):62-8. PubMed ID: 18174952
[TBL] [Abstract][Full Text] [Related]
3. Effect of 17beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17beta-estradiol serum kinetics and bone mass in rats.
Bauss F; Esswein A; Reiff K; Sponer G; Müller-Beckmann B
Calcif Tissue Int; 1996 Sep; 59(3):168-73. PubMed ID: 8694893
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
Diel P; Hertrampf T; Seibel J; Laudenbach-Leschowsky U; Kolba S; Vollmer G
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):60-70. PubMed ID: 17049845
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats.
Westerlind KC; Gibson KJ; Malone P; Evans GL; Turner RT
J Bone Miner Res; 1998 Jun; 13(6):1023-31. PubMed ID: 9626634
[TBL] [Abstract][Full Text] [Related]
6. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.
Lotinun S; Westerlind KC; Turner RT
J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149
[TBL] [Abstract][Full Text] [Related]
7. Long-term sensitivity of uterus and hypothalamus/pituitary axis to 17beta-estradiol is higher than that of bone in rats.
Erben RG; Brunner KS; Breig B
J Bone Miner Res; 2004 Nov; 19(11):1827-32. PubMed ID: 15476583
[TBL] [Abstract][Full Text] [Related]
8. Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats.
Rimoldi G; Christoffel J; Wuttke W
Menopause; 2006; 13(4):669-77. PubMed ID: 16837889
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
10. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats.
Xu S; Zhu BT; Cai MX; Conney AH
J Pharmacol Exp Ther; 2001 Apr; 297(1):50-6. PubMed ID: 11259527
[TBL] [Abstract][Full Text] [Related]
12. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
Sibonga JD; Lotinun S; Evans GL; Pribluda VS; Green SJ; Turner RT
Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
[TBL] [Abstract][Full Text] [Related]
13. Cognitive effects of long-term dydrogesterone treatment used alone or with estrogen on rat menopausal models of different ages.
Liu J; Lin H; Huang Y; Liu Y; Wang B; Su F
Neuroscience; 2015 Apr; 290():103-14. PubMed ID: 25637796
[TBL] [Abstract][Full Text] [Related]
14. Comparison of estrogenic responses in bone and uterus depending on the parity status in Lewis rats.
Keiler AM; Bernhardt R; Scharnweber D; Jarry H; Vollmer G; Zierau O
J Steroid Biochem Mol Biol; 2013 Jan; 133():101-9. PubMed ID: 23032373
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland.
Gallo D; Zannoni GF; Martinelli E; Ferlini C; Fabrizi M; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2006; 13(1):72-9. PubMed ID: 16607101
[TBL] [Abstract][Full Text] [Related]
16. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term treatment with estradiol or clomiphene citrate on bone maintenance, and pituitary and uterine weights in ovariectomized rats.
Chakraborty PK; Brown JL; Ruff CB; Nelson MF; Mitchell AS
J Steroid Biochem Mol Biol; 1991; 40(4-6):725-9. PubMed ID: 1958570
[TBL] [Abstract][Full Text] [Related]
18. Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats.
Fujisaki J; Tokunaga Y; Takahashi T; Shimojo F; Kimura S; Hata T
J Drug Target; 1998; 5(2):129-38. PubMed ID: 9588869
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.
Murphy LJ; Friesen HG
Endocrinology; 1988 Jan; 122(1):325-32. PubMed ID: 3335211
[TBL] [Abstract][Full Text] [Related]
20. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
Labrie F; El-Alfy M; Berger L; Labrie C; Martel C; Bélanger A; Candas B; Pelletier G
Endocrinology; 2003 Nov; 144(11):4700-6. PubMed ID: 12960051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
